Cargando…
Quantitative Testing of Prescriber Knowledge Regarding the Risks and Safe Use of Albiglutide
BACKGROUND: The risk of pancreatitis and potential risk of medullary thyroid carcinoma associated with glucagon-like peptide-1 receptor agonists prompted the US Food and Drug Administration to require a Risk Evaluation and Mitigation Strategy for albiglutide, including education for prescribers and...
Autores principales: | Koro, Carol, Pientka, Janet, Bainbridge, Veronica, O’Donnell, Natalie, Stender, Monika, Stemhagen, Annette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825391/ https://www.ncbi.nlm.nih.gov/pubmed/29218595 http://dx.doi.org/10.1007/s40801-017-0128-3 |
Ejemplares similares
-
Knowledge and Understanding of the Safety and Efficacy Aspects of BRIDION(®) Among Canadian Anesthesiologists
por: Stemhagen, Annette, et al.
Publicado: (2020) -
Generalized Edema Caused by Albiglutide: A Case Report
por: Aziz, Kashif, et al.
Publicado: (2018) -
Patient Understanding of the Neuropsychiatric Risks Associated with Branded Bupropion Hydrochloride Products Used for Smoking Cessation
por: Ascher, John, et al.
Publicado: (2018) -
Once-weekly albiglutide in the management of type 2 diabetes: patient considerations
por: Woodward, Heather N, et al.
Publicado: (2014) -
Albiglutide Does Not Prolong QTc Interval in Healthy Subjects: A Thorough ECG Study
por: Darpo, Borje, et al.
Publicado: (2014)